Intraoperative ketorolac in high-risk breast cancer patients. A prospective, randomized, placebo-controlled clinical trial

BACKGROUND: Ketorolac has been associated with a lower risk of recurrence in retrospective studies, especially in patients with positive inflammatory markers. It is still unknown whether a single dose of pre-incisional ketorolac can prolong recurrence-free survival. METHODS: The KBC trial is a multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Forget, Patrice, Bouche, Gauthier, Duhoux, Francois P., Coulie, Pierre G., Decloedt, Jan, Dekleermaker, Alain, Guillaume, Jean-Edouard, Ledent, Marc, Machiels, Jean-Pascal, Mustin, Véronique, Swinnen, Walter, van Maanen, Aline, Vander Essen, Lionel, Verougstraete, Jean-Christophe, De Kock, Marc, Berliere, Martine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892544/
https://www.ncbi.nlm.nih.gov/pubmed/31800611
http://dx.doi.org/10.1371/journal.pone.0225748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892544/
https://www.ncbi.nlm.nih.gov/pubmed/31800611
http://dx.doi.org/10.1371/journal.pone.0225748

Ejemplares similares